Infimer Ltd Logo

Infimer Ltd

INFR-M.TA

(0.0)
Stock Price

47,20 ILA

-2793.81% ROA

28.15% ROE

-0.58x PER

Market Cap.

1.311.090,00 ILA

-4.91% DER

0% Yield

0% NPM

Infimer Ltd Stock Analysis

Infimer Ltd Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Infimer Ltd Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (0) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Infimer Ltd Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Infimer Ltd Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Infimer Ltd Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Infimer Ltd Revenue
Year Revenue Growth
2013 0
2014 0 0%
2015 0 0%
2016 19 100%
2017 166 88.55%
2018 0 0%
2019 248 100%
2020 378 34.39%
2021 0 0%
2022 0 0%
2023 0 0%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Infimer Ltd Research and Development Expenses
Year Research and Development Expenses Growth
2013 371
2014 1.505 75.35%
2015 2.212 31.96%
2016 4.353 49.18%
2017 4.266 -2.04%
2018 4.935 13.56%
2019 2.470 -99.8%
2020 1.388 -77.95%
2021 98 -1316.33%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Infimer Ltd General and Administrative Expenses
Year General and Administrative Expenses Growth
2013 130
2014 441 70.52%
2015 1.311 66.36%
2016 2.665 50.81%
2017 3.112 14.36%
2018 3.953 21.27%
2019 5.065 21.95%
2020 1.299 -289.92%
2021 1.357 4.27%
2022 1.928 29.62%
2023 5.700 66.18%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Infimer Ltd EBITDA
Year EBITDA Growth
2013 -500
2014 -2.181 77.07%
2015 -3.367 35.22%
2016 -7.023 52.06%
2017 -6.400 -9.73%
2018 -7.707 16.96%
2019 -6.918 -11.41%
2020 -3.147 -119.83%
2021 1.499 309.94%
2022 -1.742 186.05%
2023 -442 -294.12%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Infimer Ltd Gross Profit
Year Gross Profit Growth
2013 0
2014 0 0%
2015 0 0%
2016 -479 100%
2017 -760 36.97%
2018 0 0%
2019 -1.954 100%
2020 -899 -117.35%
2021 -401 -124.19%
2022 0 0%
2023 0 0%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Infimer Ltd Net Profit
Year Net Profit Growth
2013 -506
2014 -2.213 77.14%
2015 -4.281 48.31%
2016 -7.212 40.64%
2017 -6.713 -7.43%
2018 -8.649 22.38%
2019 -11.382 24.01%
2020 -7.989 -42.47%
2021 -484 -1550.62%
2022 -2.513 80.74%
2023 -3.230 22.2%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Infimer Ltd Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2013 -1
2014 -4 100%
2015 -5 0%
2016 -7 42.86%
2017 -6 -16.67%
2018 -7 0%
2019 -8 14.29%
2020 -5 -40%
2021 0 0%
2022 -1 100%
2023 -2 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Infimer Ltd Free Cashflow
Year Free Cashflow Growth
2013 -240
2014 -988 75.71%
2015 -8.303 88.1%
2016 -8.241 -0.75%
2017 -5.321 -54.88%
2018 -10.188 47.77%
2019 -11.466 11.15%
2020 -1.596 -618.42%
2021 -1.115 -43.14%
2022 -1.562 28.62%
2023 -83 -1804.88%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Infimer Ltd Operating Cashflow
Year Operating Cashflow Growth
2013 -233
2014 -988 76.42%
2015 -4.374 77.41%
2016 -6.350 31.12%
2017 -4.956 -28.13%
2018 -7.891 37.19%
2019 -8.925 11.59%
2020 -1.591 -460.97%
2021 -1.115 -42.69%
2022 -1.562 28.62%
2023 -83 -1804.88%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Infimer Ltd Capital Expenditure
Year Capital Expenditure Growth
2013 7
2014 0 0%
2015 3.929 100%
2016 1.891 -107.77%
2017 365 -418.08%
2018 2.297 84.11%
2019 2.541 9.6%
2020 5 -50720%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Infimer Ltd Equity
Year Equity Growth
2014 -2.177
2015 4.232 151.44%
2016 6.139 31.06%
2017 2.512 -144.39%
2018 8.703 71.14%
2019 106 -8110.38%
2020 -9.519 101.11%
2021 -8.059 -18.12%
2022 -10.021 19.58%
2023 -11.673 14.15%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Infimer Ltd Assets
Year Assets Growth
2014 48
2015 5.942 99.19%
2016 8.747 32.07%
2017 7.235 -20.9%
2018 14.184 48.99%
2019 11.706 -21.17%
2020 2.382 -391.44%
2021 1.330 -79.1%
2022 172 -673.26%
2023 97 -77.32%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Infimer Ltd Liabilities
Year Liabilities Growth
2014 2.225
2015 1.710 -30.12%
2016 1.518 -12.65%
2017 2.957 48.66%
2018 2.528 -16.97%
2019 11.600 78.21%
2020 8.595 -34.96%
2021 9.389 8.46%
2022 10.193 7.89%
2023 11.770 13.4%

Infimer Ltd Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-1.51
Price to Earning Ratio
-0.58x
Price To Sales Ratio
0x
POCF Ratio
-2.43
PFCF Ratio
-2039.02
Price to Book Ratio
-0.15
EV to Sales
0
EV Over EBITDA
-1322.27
EV to Operating CashFlow
-2038.92
EV to FreeCashFlow
-2038.92
Earnings Yield
-1.74
FreeCashFlow Yield
-0
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
14.06
Graham NetNet
-6.53

Income Statement Metrics

Net Income per Share
-1.51
Income Quality
0.24
ROE
0.28
Return On Assets
-27.94
Return On Capital Employed
0.2
Net Income per EBT
0.95
EBT Per Ebit
1.31
Ebit per Revenue
0
Effective Tax Rate
0.13

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0
Operating Profit Margin
0
Pretax Profit Margin
0
Net Profit Margin
0

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.36
Free CashFlow per Share
-0.36
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.19
Return on Tangible Assets
-27.94
Days Sales Outstanding
0
Days Payables Outstanding
0
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,03
Book Value per Share
-5,82
Tangible Book Value per Share
-6.51
Shareholders Equity per Share
-5.82
Interest Debt per Share
0.29
Debt to Equity
-0.05
Debt to Assets
5.28
Net Debt to EBITDA
0.06
Current Ratio
0.01
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-0.05
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Infimer Ltd Dividends
Year Dividends Growth

Infimer Ltd Profile

About Infimer Ltd

Infimer Ltd, through its subsidiary, Infimer Technologies Ltd., develops technology and production processes for converting municipal solid waste. It produces Infimer, a thermoplastic composite material which can be used as a raw materials for the plastics industry. The company was incorporated in 1985 and is based in Avihayil, Israel.

CEO
Mr. Doron Turgeman
Employee
0
Address
6 Hashomer Street
Avihayil, 4291000

Infimer Ltd Executives & BODs

Infimer Ltd Executives & BODs
# Name Age
1 Mr. Doron Turgeman
Chief Executive Officer
70
2 Mr. Uri Ben-Or CPA, CPA, M.B.A., MBA
Chief Financial Officer
70
3 Mr. Yuval Tamir
Chief Technology Officer
70
4 Ms. Tal Tamir
Vice President of Marketing & Operations
70

Infimer Ltd Competitors